Financials data is unavailable for this security.
View more
Year on year Cochlear Ltd grew revenues 15.47% from 1.94bn to 2.24bn while net income improved 18.70% from 300.60m to 356.80m.
| Gross margin | 75.84% |
|---|---|
| Net profit margin | 15.96% |
| Operating margin | 21.25% |
| Return on assets | 13.43% |
|---|---|
| Return on equity | 19.88% |
| Return on investment | 17.39% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Cochlear Ltd fell by 41.90m. However, the company earned 388.80m from its operations for a Cash Flow Margin of 17.39%. In addition the company used 105.70m on investing activities and also paid 323.80m in financing cash flows.
| Cash flow per share | 6.72 |
|---|---|
| Price/Cash flow per share | 43.41 |
| Book value per share | 28.10 |
|---|---|
| Tangible book value per share | 21.22 |
More ▼
Balance sheet in AUDView more
| Current ratio | 2.30 |
|---|---|
| Quick ratio | 1.68 |
| Total debt/total equity | 0.1324 |
|---|---|
| Total debt/total capital | 0.1169 |
More ▼
Growth rates in AUD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 24.24% and 19.01%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.21% |
|---|---|
| Div growth rate (5 year) | 4.44% |
| Payout ratio (TTM) | 75.25% |
| EPS growth(5 years) | 2.52 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 19.03 |
More ▼
